| Host: |
Goat |
| Applications: |
Pep-ELISA/FC |
| Reactivity: |
Human/Dog/Pig |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Goat polyclonal antibody anti-PLA2R1 (Internal) is suitable for use in ELISA and Flow Cytometry research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
| Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Concentration: |
0.5 mg/mL |
| Dilution Range: |
FC-Flow cytometric analysis of HEK293 cells. 10ug/mlELISA-antibody detection limit dilution 1:1000. |
| Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
| Gene Symbol: |
PLA2R1 |
| Gene ID: |
22925 |
| Uniprot ID: |
PLA2R_HUMAN |
| Immunogen Region: |
Internal |
| Accession Number: |
NP_031392.3; NP_001007268.1; NP_001182570.1 |
| Specificity: |
This antibody is expected to recognize all reported isoforms (NP_031392.3; NP_001007268.1; NP_001182570.1). |
| Immunogen Sequence: |
EKKKDTPKQHGT |
| Post Translational Modifications | The secretory phospholipase A2 receptor form may be produced by the action of metalloproteinases. It contains all extracellular domains and only lacks transmembrane and cytosolic regions. It is however unclear whether this form is produced by proteolytic cleavage as suggested by some experiments, or by alternative splicing, as in the case of isoform 2 that shares all characteristics of secretory phospholipase A2 receptor form. |
| Function | Receptor for secretory phospholipase A2 (sPLA2). Acts as a receptor for phospholipase sPLA2-IB/PLA2G1B but not sPLA2-IIA/PLA2G2A. Also able to bind to snake PA2-like toxins. Although its precise function remains unclear, binding of sPLA2 to its receptor participates in both positive and negative regulation of sPLA2 functions as well as clearance of sPLA2. Binding of sPLA2-IB/PLA2G1B induces various effects depending on the cell type, such as activation of the mitogen-activated protein kinase (MAPK) cascade to induce cell proliferation, the production of lipid mediators, selective release of arachidonic acid in bone marrow-derived mast cells. In neutrophils, binding of sPLA2-IB/PLA2G1B can activate p38 MAPK to stimulate elastase release and cell adhesion. May be involved in responses in pro-inflammatory cytokine productions during endotoxic shock. Also has endocytic properties and rapidly internalizes sPLA2 ligands, which is particularly important for the clearance of extracellular sPLA2s to protect their potent enzymatic activities. The soluble secretory phospholipase A2 receptor form is circulating and acts as a negative regulator of sPLA2 functions by blocking the biological functions of sPLA2-IB/PLA2G1B. In podocytes, binding of sPLA2-IB/PLA2G1B can regulate podocyte survival and glomerular homeostasis. |
| Protein Name | Secretory Phospholipase A2 ReceptorPla2-RPla2r180 Kda Secretory Phospholipase A2 ReceptorC-Type Lectin Domain Family 13 Member CM-Type Receptor Cleaved Into - Soluble Secretory Phospholipase A2 ReceptorSoluble Pla2-RSoluble Pla2r |
| Database Links | Reactome: R-HSA-1482788Reactome: R-HSA-1482801Reactome: R-HSA-1482839Reactome: R-HSA-1482922Reactome: R-HSA-1482925Reactome: R-HSA-1483166 |
| Cellular Localisation | Cell MembraneSingle-Pass Type I Membrane ProteinSoluble Secretory Phospholipase A2 Receptor: SecretedIsoform 2: Secreted |
| Alternative Antibody Names | Anti-Secretory Phospholipase A2 Receptor antibodyAnti-Pla2-R antibodyAnti-Pla2r antibodyAnti-180 Kda Secretory Phospholipase A2 Receptor antibodyAnti-C-Type Lectin Domain Family 13 Member C antibodyAnti-M-Type Receptor Cleaved Into - Soluble Secretory Phospholipase A2 Receptor antibodyAnti-Soluble Pla2-R antibodyAnti-Soluble Pla2r antibodyAnti-PLA2R1 antibodyAnti-CLEC13C antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
